JP2005514030A5 - - Google Patents

Download PDF

Info

Publication number
JP2005514030A5
JP2005514030A5 JP2003558131A JP2003558131A JP2005514030A5 JP 2005514030 A5 JP2005514030 A5 JP 2005514030A5 JP 2003558131 A JP2003558131 A JP 2003558131A JP 2003558131 A JP2003558131 A JP 2003558131A JP 2005514030 A5 JP2005514030 A5 JP 2005514030A5
Authority
JP
Japan
Prior art keywords
binding
binding protein
linker
polypeptide
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003558131A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514030A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/038985 external-priority patent/WO2003057829A2/en
Publication of JP2005514030A publication Critical patent/JP2005514030A/ja
Publication of JP2005514030A5 publication Critical patent/JP2005514030A5/ja
Withdrawn legal-status Critical Current

Links

JP2003558131A 2001-12-26 2002-12-26 Vhおよびvlドメインから多重特異性多価薬剤を製造する方法 Withdrawn JP2005514030A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34210301P 2001-12-26 2001-12-26
PCT/US2002/038985 WO2003057829A2 (en) 2001-12-26 2002-12-26 Methods of generating multispecific, multivalent agents from vh and vl domains

Publications (2)

Publication Number Publication Date
JP2005514030A JP2005514030A (ja) 2005-05-19
JP2005514030A5 true JP2005514030A5 (https=) 2006-02-23

Family

ID=23340336

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003558131A Withdrawn JP2005514030A (ja) 2001-12-26 2002-12-26 Vhおよびvlドメインから多重特異性多価薬剤を製造する方法

Country Status (12)

Country Link
US (1) US20030162709A1 (https=)
EP (1) EP1468097A4 (https=)
JP (1) JP2005514030A (https=)
KR (1) KR20040091616A (https=)
AU (1) AU2002364531A1 (https=)
BR (1) BR0215403A (https=)
CA (1) CA2471868A1 (https=)
IL (1) IL162732A0 (https=)
MX (1) MXPA04006327A (https=)
PL (1) PL372144A1 (https=)
RU (1) RU2004122702A (https=)
WO (1) WO2003057829A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
KR101027889B1 (ko) * 2001-10-15 2011-04-07 아이비씨 파마슈티컬스, 인코퍼레이티드 친화력 증강제
US8435529B2 (en) 2002-06-14 2013-05-07 Immunomedics, Inc. Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
US9770517B2 (en) 2002-03-01 2017-09-26 Immunomedics, Inc. Anti-Trop-2 antibody-drug conjugates and uses thereof
WO2003074566A2 (en) * 2002-03-01 2003-09-12 Immunomedics, Inc. Rs7 antibodies
US20040022726A1 (en) * 2002-06-03 2004-02-05 Goldenberg David M. Methods and compositions for intravesical therapy of bladder cancer
CN1767860A (zh) * 2003-01-31 2006-05-03 免疫医疗公司 施用治疗和诊断剂的方法和组合物
US20050003403A1 (en) * 2003-04-22 2005-01-06 Rossi Edmund A. Polyvalent protein complex
CN1326881C (zh) * 2003-09-29 2007-07-18 中国人民解放军军事医学科学院基础医学研究所 一种三价双特异性抗体,其制备方法及用途
US20060057062A1 (en) * 2004-09-10 2006-03-16 Trotter Dinko G Compositions and methods useful in pretargeted imaging
ES2665422T3 (es) 2005-03-03 2018-04-25 Immunomedics Inc. Anticuerpos L243 humanizados
US9339559B2 (en) 2005-09-09 2016-05-17 Georgia State University Research Foundation, Inc. Targeted contrast agents and methods for targeting contrast agents
HRP20140338T1 (hr) 2005-07-25 2014-06-20 Emergent Product Development Seattle, Llc Smanjenje broja b-stanica upotrebom molekula koje se specifiäśno vežu na cd37 i cd20
CA2621763C (en) * 2005-09-09 2021-04-06 Georgia State University Research Foundation, Inc. Targeted contrast agents and methods for targeting contrast agents
DK2500360T3 (en) 2005-10-31 2015-10-26 Oncomed Pharm Inc Compositions and methods for the diagnosis and treatment of cancer
US7723477B2 (en) 2005-10-31 2010-05-25 Oncomed Pharmaceuticals, Inc. Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
WO2007146968A2 (en) 2006-06-12 2007-12-21 Trubion Pharmaceuticals, Inc. Single-chain multivalent binding proteins with effector function
WO2008019123A2 (en) 2006-08-04 2008-02-14 Georgia State University Research Foundation, Inc. Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity
EP2097507B1 (en) 2006-12-14 2015-05-06 Georgia State University Research Foundation, Inc. Analyte sensors and use thereof for detecting analyte activity
EP2257316B1 (en) 2008-04-02 2018-11-07 Georgia State University Research Foundation, Inc. Contrast agents, methods for preparing contrast agents, and methods of imaging
EP2365003A1 (en) 2008-04-11 2011-09-14 Emergent Product Development Seattle, LLC CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
CN103002911B (zh) 2008-09-26 2015-08-26 昂考梅德药品有限公司 卷曲蛋白结合药剂及其应用
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt拮抗劑及治療和篩選方法
CA2794674A1 (en) 2010-04-01 2011-10-06 Oncomed Pharmaceuticals, Inc. Frizzled-binding agents and uses thereof
WO2013184786A2 (en) * 2012-06-05 2013-12-12 Georgia State University Research Foundation, Inc. Contrast agents, methods for preparing contrast agents, and methods of imaging
US9382329B2 (en) 2012-08-14 2016-07-05 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to Trop-2 expressing cells
WO2014066328A1 (en) 2012-10-23 2014-05-01 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using wnt pathway-binding agents
JP2016510411A (ja) 2013-02-04 2016-04-07 オンコメッド ファーマシューティカルズ インコーポレイテッド Wnt経路インヒビターによる処置の方法およびモニタリング
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
EP2930188A1 (en) * 2014-04-13 2015-10-14 Affimed Therapeutics AG Trifunctional antigen-binding molecule
WO2016172427A1 (en) 2015-04-22 2016-10-27 Immunomedics, Inc. Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
EP3352760B1 (en) 2015-09-21 2026-03-11 Aptevo Research and Development LLC Cd3 binding polypeptides
EP3156417A1 (en) * 2015-10-13 2017-04-19 Affimed GmbH Multivalent fv antibodies
US11571476B2 (en) 2017-12-11 2023-02-07 Taipei Medical University Anti-tumor/anti-tumor associated fibroblast/anti-hapten trispecific antibodies and use thereof
TWI870708B (zh) * 2017-12-12 2025-01-21 臺北醫學大學 多特異性抗體及其用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382317D1 (de) * 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US6121424A (en) * 1991-11-25 2000-09-19 Enzon, Inc. Multivalent antigen-binding proteins
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
US5132405A (en) * 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6096289A (en) * 1992-05-06 2000-08-01 Immunomedics, Inc. Intraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapy
SG41929A1 (en) * 1992-09-25 1997-08-15 Commw Scient Ind Res Org Target binding polypeptide
ATE199392T1 (de) * 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
US5989830A (en) * 1995-10-16 1999-11-23 Unilever Patent Holdings Bv Bifunctional or bivalent antibody fragment analogue
EP0888125B1 (en) * 1996-03-20 2004-05-26 Immunomedics, Inc. GLYCOSYLATED IgG ANTIBODIES
ES2225961T3 (es) * 1996-04-04 2005-03-16 Unilever N.V. Proteina de union a antigeno multivalente y multiespecifica.
US6183744B1 (en) * 1997-03-24 2001-02-06 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
WO1999066951A2 (en) * 1998-06-22 1999-12-29 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy

Similar Documents

Publication Publication Date Title
JP2005514030A5 (https=)
RU2004122702A (ru) Способы получения полиспецифичных, поливалентных средств из vh и vl доменов
JP4323317B2 (ja) 可変領域配列のクローニング方法
JP2002513556A5 (https=)
CA2398155A1 (en) Methods and compositions for linking binding domains in nucleic acid binding proteins
JP2006526414A5 (https=)
JP2004532038A5 (https=)
JP2011523550A5 (https=)
WO2003072803A2 (en) Nanostructures containing antibody assembly units
JP2007501011A5 (https=)
JP2005528884A5 (https=)
CN105080183B (zh) 多特异性受体的改进的纯化
CN106928363B (zh) 一种FAP纳米抗体Nb12
JP2005518344A5 (https=)
RU2004114878A (ru) Агенты, увеличивающие аффинность
CN106928364B (zh) 一种FAP纳米抗体Nb26
JP2005512016A5 (https=)
JP2004535795A5 (https=)
CN106928358B (zh) 一种CD105纳米抗体Nb168
Yuan et al. Construction of human nonimmune library and selection of scFvs against IL-33
CN106928365B (zh) 一种FAP纳米抗体Nb36
US20060263787A1 (en) Immunoglobulin-like variable chain binding polypeptides and methods of use
JP4521519B2 (ja) 部分ヒストンテイル型イムノポーター
JPWO2022129572A5 (https=)
CN106928359B (zh) 一种CD105纳米抗体Nb59